Imagen de Portada

The Whys, Whens, and Hows of Futility Monitoring

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Karen M. Higgins, Jyoti Zalkikar, Jialu Zhang, Yan Wang, Rebecca Chiu, Mat Soukup, Yeh‐Fong Chen, Greg Levin
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Statistics in Medicine
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Futility Monitoring in Clinical Trials
por: Ana M. Ortega‐Villa, et al.
Publicado: (2025)

Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule
por: Juhee Lee, et al.
Publicado: (2024)

Informative Futility Rules Based on Conditional Assurance
por: Vladimir Dragalin
Publicado: (2026)

Futility Analyses for the MCP ‐Mod Methodology Based on Longitudinal Models
por: Björn Bornkamp, et al.
Publicado: (2025)

Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials
por: Jialu Fang, et al.
Publicado: (2024)

Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring
por: Shu Jiang, et al.
Publicado: (2025)

Identification and Estimation of the Average Causal Effects Under Dietary Substitution Strategies
por: Yu‐Han Chiu, et al.
Publicado: (2025)

Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
por: Xiaotian Chen, et al.
Publicado: (2025)

Negative Control Outcome Adjustment in Early‐Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants
por: Ethan Ashby, et al.
Publicado: (2025)

Database Cancellation: The "Hows" and "Whys"
por: Shapiro, Steven
Publicado: (2012)

Guidelines and Best Practices for the Use of Targeted Maximum Likelihood and Machine Learning When Estimating Causal Effects of Exposures on Time‐To‐Event Outcomes
por: Denis Talbot, et al.
Publicado: (2025)

Sequential Event Rate Monitoring
por: Dong‐Yun Kim, et al.
Publicado: (2026)

An Information Criterion Approach for Assessing Agreement When Comparing Two Methods of Measurement
por: Charles Y. Tan, et al.
Publicado: (2025)

Incorporating Auxiliary Information into Assessment of Accuracy and Discrimination of Risk Models When Some Predictors are Missing
por: Ruth M. Pfeiffer, et al.
Publicado: (2026)

Multiple Imputation of Missing Covariates When Using the Fine–Gray Model
por: Edouard F. Bonneville, et al.
Publicado: (2025)

The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints
por: Xinran Huang, et al.
Publicado: (2024)

Efficient Computation of High‐Dimensional Penalized Piecewise Constant Hazard Random Effects Models
por: Hillary M. Heiling, et al.
Publicado: (2025)

A General Framework to Assess Complex Heterogeneity in the Strength of a Surrogate Marker
por: Rebecca Knowlton, et al.
Publicado: (2025)

Dose Individualization for Phase I Cancer Trials With Broadened Eligibility
por: Rebecca B. Silva, et al.
Publicado: (2024)

Moving Toward Best Practice When Using Propensity Score Weighting in Survey Observational Studies
por: Yukang Zeng, et al.
Publicado: (2026)

Linear Mixed Modeling of Federated Data When Only the Mean, Covariance, and Sample Size Are Available
por: Marie Analiz April Limpoco, et al.
Publicado: (2024)

A Sensitivity Analysis Framework Using the Proxy Pattern–Mixture Model for Generalization of Experimental Results
por: Rebecca R. Andridge, et al.
Publicado: (2025)

A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events
por: Thomas R. Fleming, et al.
Publicado: (2025)

Design and Analysis of Group Sequential Trials for Repeated Measurements When Pipeline Data Occurs: A Tutorial
por: Corine Baayen, et al.
Publicado: (2025)

Robust inference for causal mediation analysis of recurrent event data
por: Yan‐Lin Chen, et al.
Publicado: (2024)

Risk‐Profile Based Monitoring Intervals for Multivariate Longitudinal Biomarker Measurements and Competing Events With Applications in Stable Heart Failure
por: Teun B. Petersen, et al.
Publicado: (2025)

Futility and hope
por: Lucy Zhonglu Shi
Publicado: (2026)

Categorisation of continuous covariates for stratified randomisation: How should we adjust?
por: Thomas R. Sullivan, et al.
Publicado: (2024)

A Hierarchical Bayesian Model for Estimating Age‐Specific COVID‐19 Infection Fatality Rates in Developing Countries
por: Sierra Pugh, et al.
Publicado: (2024)

Optimal subsampling for semi‐parametric accelerated failure time models with massive survival data using a rank‐based approach
por: Zehan Yang, et al.
Publicado: (2024)

Multivariate Regression With Dependence Structures: Evaluating Associations Between Plasma Metabolomics and Alcohol Intake in Older Adults
por: Yifan Yang, et al.
Publicado: (2026)

Using Propensity Score Weighting With Clustered Data When the Treatment Is Applied at the Level of the Cluster and Outcomes Are Assessed at the Level of the Individual: The Observational Analog of Cluster Randomization Trials
por: Peter C. Austin
Publicado: (2026)

Overcoming Model Uncertainty — How Equivalence Tests Can Benefit From Model Averaging
por: Niklas Hagemann, et al.
Publicado: (2025)

Determining sample size in a personalized randomized controlled (PRACTical) trial
por: Rebecca M. Turner, et al.
Publicado: (2024)

Covariate Balancing With Measurement Error
por: Xialing Wen, et al.
Publicado: (2025)

Statistical considerations in model‐based dose finding for binary responses under model uncertainty
por: Zhiwu Yan, et al.
Publicado: (2024)

Response to Letter to the Editor “Comments on ‘Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods’”
por: Guoqiao Wang, et al.
Publicado: (2025)

Modeling intra‐individual inter‐trial EEG response variability in autism
por: Mingfei Dong, et al.
Publicado: (2024)

A Causal Mediation Approach to Account for Interaction of Treatment and Intercurrent Events: Using Hypothetical Strategy
por: Kunpeng Wu, et al.
Publicado: (2024)

A New Algorithm for Sampling Parameters in a Structured Correlation Matrix With Application to Estimating Optimal Combinations of Muscles to Quantify Progression in Duchenne Muscular Dystrophy
por: Michael K. Kim, et al.
Publicado: (2025)